BODY MASS INDEX DURING ACUTE EXACERBATION AND STABLE COPD: A PROSPECTIVE SINGLE-CENTRE STUDY

  • Irina Angelovska University clinic of pulmonology and allergology, Skopje, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, North Macedonia
  • Sava Pejkovska University clinic of pulmonology and allergology, Skopje, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, North Macedonia
  • Angela Debreshlioska University clinic of pulmonology and allergology, Skopje, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, North Macedonia
  • Irfan Ismaili University clinic of pulmonology and allergology, Skopje, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, North Macedonia
  • Sonja Momcilovikj University clinic of pulmonology and allergology, Skopje, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, North Macedonia
  • Kristina Dimitrievikj University clinic of pulmonology and allergology, Skopje, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, North Macedonia
  • Milena Miletic Gjoreska University clinic of pulmonology and allergology, Skopje, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, North Macedonia
  • Biljana Bojadzieva Stojanoska Institute of Anatomy, Faculty of Medicine, ``St. Ciril and Methodius`` University in Skopje, North Macedonia

Abstract

Background: Body mass index (BMI) is a readily available anthropometric measure in chronic obstructive pulmonary disease (COPD), but its distribution and clinical associations may vary across populations and between women and men. Aim: To evaluate BMI during acute exacerbation and stable COPD, focusing on longitudinal change, sex differences, and relationships with lung function and blood gas parameters. Methods: This prospective single-center study included 60 patients with COPD assessed during acute exacerbation; 54 completed a second assessment 3 to 6 months later during stable disease. BMI, spirometry, and arterialized capillary blood gas parameters were evaluated at both visits. Paired BMI values, sex differences, and associations with clinical parameters were analyzed using non-parametric tests. Sex differences in BMI were additionally adjusted for age. Results: Mean age was 63.0 +/- 9.1 years; 38 patients were men and 22 were women. More than 80% were overweight or obese at both visits, and none were underweight. In 54 paired patients, mean BMI increased from 30.51 +/- 7.22 to 30.87 +/- 7.30 kg/m2 (p=0.018), although the median individual change was 0.00 kg/m2. Women had higher BMI than men during exacerbation (34.92 +/- 8.62 vs. 27.91 +/- 4.36 kg/m2; p=0.001) and stable disease (35.08 +/- 9.14 vs. 28.40 +/- 4.52 kg/m2; p=0.006). These differences remained significant after age adjustment. No consistent association was observed between BMI and FEV1 or blood gas parameters. Conclusion: BMI remained largely stable between acute exacerbation and stable COPD. Overweight and obesity predominated, particularly among women. BMI was not consistently associated with airflow limitation or blood gas abnormalities.


Keywords: chronic obstructive pulmonary disease; body mass index; obesity; sex differences; acute exacerbation; stable COPD.

References

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report. GOLD; 2025.
2. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012.
3. Schols AM, Ferreira IM, Franssen FME, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J. 2014;44(6):1504–1520.
4. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–1861.
5. Franssen FME, O'Donnell DE, Goossens GH, Blaak EE, Schols AMWJ. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008;63(12):1110–1117.
6. García-Rio F, Soriano JB, Miravitlles M, et al. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS One. 2014;9(8):e105220.
7. Guo Y, Zhang T, Wang Z, et al. Body mass index and mortality in chronic obstructive pulmonary disease: a dose-response meta-analysis. Medicine (Baltimore). 2016;95(28):e4225.
8. Putcha N, Anzueto AR, Calverley PMA, et al. Mortality and exacerbation risk by body mass index in patients with COPD in TIOSPIR and UPLIFT. Ann Am Thorac Soc. 2022;19(2):204–213.
9. Vermeeren MAP, Schols AMWJ, Wouters EFM. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J. 1997;10(10):2264–2269.
10. Han MK. Chronic obstructive pulmonary disease in women: a biologically focused review with a systematic search strategy. Int J Chron Obstruct Pulmon Dis. 2020;15:711–721.
11. Alonso-Pérez T, García-Castillo E, Ancochea J, et al. Sex differences between women and men with COPD: a new analysis of the 3CIA study. Respir Med. 2020;171:106105.
12. Souto-Miranda S, van 't Hul AJ, Vaes AW, et al. Differences in pulmonary and extra-pulmonary traits between women and men with chronic obstructive pulmonary disease. J Clin Med. 2022;11(13):3680.
Published
2026-11-18
How to Cite
ANGELOVSKA, Irina et al. BODY MASS INDEX DURING ACUTE EXACERBATION AND STABLE COPD: A PROSPECTIVE SINGLE-CENTRE STUDY. Journal of Morphological Sciences, [S.l.], v. 9, n. 3, p. 124-132, nov. 2026. ISSN 2545-4706. Available at: <https://jms.mk/jms/article/view/vol9no3-15>. Date accessed: 18 nov. 2026.
Section
Articles